enfortumab vedotin (Padcev) Report issue

Biologics mAb ADC Approved FDA Accelerated Approval FDA Priority Review FDA
Back

Drug Pricing Summary

VA Big4

$1611.6600 - $2417.4900

VA FSS

$2099.4000 - $3149.1000

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
enfortumab vedotin 20 mg / 2 mL (2 mL INJECTION) $1611.6600 VA Big4
  • PADCEV (1)
  • Seattle Genetics, Inc.
    enfortumab vedotin 20 mg / 2 mL (2 mL INJECTION) $2099.4000 VA FSS
  • PADCEV (1)
  • Seattle Genetics, Inc.
    enfortumab vedotin 30 mg / 3 mL (3 mL INJECTION) $2417.4900 VA Big4
  • PADCEV (1)
  • Seattle Genetics, Inc.
    enfortumab vedotin 30 mg / 3 mL (3 mL INJECTION) $3149.1000 VA FSS
  • PADCEV (1)
  • Seattle Genetics, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue